Keyphrases
Triple-negative Breast Cancer
100%
Breast Cancer Growth
100%
Cytokine Network
100%
IKBKE
100%
CYT387
57%
Cytokine Signaling
42%
Patient-derived Xenograft
28%
Interleukin-6
28%
Breast Cancer Cells
28%
CCL5
28%
Breast Cancer Cell Lines
14%
Triple-negative Breast Cancer Cells
14%
Tumor Growth
14%
Endothelial Cells
14%
Potent Inhibitor
14%
Signaling Network
14%
NF-B
14%
Tumor Angiogenesis
14%
Tumorigenicity
14%
MEK Inhibitor (MEKi)
14%
Potential Therapeutic Strategies
14%
Pathway Activation
14%
JAK-STAT Pathway
14%
3D Culture System
14%
Pro-tumorigenic
14%
HER2 Amplification
14%
TANK-binding Kinase 1 (TBK1)
14%
Hormone Receptor Expression
14%
Cell Line-derived Xenograft
14%
Tumor Spheroids
14%
JAK Signaling
14%
Aggressive Patient
14%
Immunology and Microbiology
Cytokine
100%
Cytokine Signaling
100%
Interleukin 6
66%
Cancer Cell
66%
Xenograft
66%
CCL5
66%
Angiogenesis
33%
Breast Cancer Cell Line
33%
Tumor Spheroid
33%
JAK-STAT Signaling
33%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Cytokine
100%
Cancer Growth
100%
Momelotinib
66%
Phosphotransferase
33%
Breast Cancer
33%
Interleukin 6
33%
Neoplasm
16%
Tumor Growth
16%
Mitogen Activated Protein Kinase Kinase Inhibitor
16%
Hormone Receptor
16%
Carcinogenicity
16%
JAK-STAT Signaling
16%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Cancer Cell
60%
Kinase
40%
Phosphotransferase
40%
Interleukin 6
40%
CCL5
40%
Tumor Progression
20%
Angiogenesis
20%
Hormone Receptor
20%
MEK Inhibitor
20%
Tumor Spheroid
20%
JAK-STAT Signaling
20%